VAN HOUTE HANS

PrivateCIK: 1817217
Location

SAN FRANCISCO, CA

VAN HOUTE HANS (Chief Financial Officer) sold 6.7% of their position (3.13K shares) of NURIX THERAPEUTICS, INC. on the open market

Open‑market sale worth $40.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 1 sale
InsiderVAN HOUTE HANSCIK 1817217
IssuerNURIX THERAPEUTICS, INC.CIK 1549595
Officer· Chief Financial Officer
Since Jul 2020
-3.13K
Net shares
Net seller
$40.1K
Total sold
1
Open market trades
0B · 1S
9
Total transactions
11.49K acquired · 14.62K disposed
Non-Derivative Transactions5

Common Stock

Direct
M · Option Exercise

Shares

+2.89K

Price / share

Trade value

% of position

8.1%
10/30/2025
35.51K38.40K

Common Stock

Direct
M · Option Exercise

Shares

+2K

Price / share

Trade value

% of position

5.2%
10/30/2025
38.40K40.40K

Common Stock

Direct
M · Option Exercise

Shares

+3.75K

Price / share

Trade value

% of position

9.3%
10/30/2025
40.40K44.15K

Common Stock

Direct
M · Option Exercise

Shares

+2.86K

Price / share

Trade value

% of position

6.5%
10/30/2025
44.15K47.01K

Common Stock

Direct
S · Sale

Shares

3.13K

Price / share

$12.80

Trade value

$40.05K

% of position

6.7%
10/30/2025
47.01K43.88K
Total

Net shares

+8.36K

Net value

-$40.05K

Derivative Transactions4

Restricted Stock Units

Direct
M · Option Exercise
Converts to

Common Stock

2.89K shares

Shares

2.89K

Strike price

0

Held after

2.89K

Exercisable

10/30/2025

Restricted Stock Units

Direct
M · Option Exercise
Converts to

Common Stock

2K shares

Shares

2K

Strike price

0

Held after

4K

Exercisable

10/30/2025

Restricted Stock Units

Direct
M · Option Exercise
Converts to

Common Stock

3.75K shares

Shares

3.75K

Strike price

0

Held after

22.50K

Exercisable

10/30/2025

Restricted Stock Units

Direct
M · Option Exercise
Converts to

Common Stock

2.86K shares

Shares

2.86K

Strike price

0

Held after

28.58K

Exercisable

10/30/2025
VAN HOUTE HANS — Insider Transaction (Form 4) Filed Oct 30, 2025 | Finecho